Immatics (IMTX) Interest Coverage Ratio (2019 - 2025)
Immatics' (IMTX) quarterly Interest Coverage Ratio came in at 75.5 in Q4 2025, up 33518.36% year-on-year from N/an in Q4 2024, and down 60.06% quarter-over-quarter from 189.04 in Q3 2025.
Immatics (IMTX) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
Immatics has disclosed Interest Coverage Ratio across 7 years of filings, most recently posting 75.5 for Q4 2025.
- Interest Coverage Ratio for Q4 2025 came in at 75.5, up 33518.36% year-over-year; the trailing twelve-month figure through Dec 2025 was 5.07 (up 28.69% YoY), and the FY2025 annual result was 4.96, down 83.02% from the prior year.
- Interest Coverage Ratio came in at 75.5 for Q4 2025 at Immatics, down from 189.04 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 189.04 in Q3 2025 to a low of 340.54 in Q1 2021.
- The 5-year median for Interest Coverage Ratio is 11.04 (2023), against an average of 14.9.
- Across the five-year window, Interest Coverage Ratio sank 187.54% in 2021 and surged 463104.62% in 2025, its largest moves.
- Immatics' Interest Coverage Ratio stood at 8.28 in 2021, then sank by 100.09% to 0.01 in 2022, then soared by 134786.25% to 9.58 in 2023, then tumbled by 97.65% to 0.22 in 2024, then soared by 33518.36% to 75.5 in 2025.
- The last three Interest Coverage Ratio figures came in at 75.5 (Q4 2025), 189.04 (Q3 2025), and 2.33 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 75.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.50 |
| Sep 30, 2025 | 189.04 |
| Jun 30, 2025 | 2.33 |
| Mar 31, 2025 | 2.65 |
| Dec 31, 2024 | 0.22 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | 87.10 |
| Mar 31, 2024 | 19.90 |
| Dec 31, 2023 | 9.58 |
| Sep 30, 2023 | 21.12 |
| Jun 30, 2023 | 12.51 |
| Mar 31, 2023 | 7.53 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | 51.47 |
| Jun 30, 2022 | 40.93 |
| Mar 31, 2022 | -61.32 |
| Dec 31, 2021 | 8.28 |
| Sep 30, 2021 | 134.51 |
| Jun 30, 2021 | 37.20 |
| Mar 31, 2021 | -340.54 |